Previous Article | Next Article ![]()
Journal of Bacteriology, June 2002, p. 3401-3405, Vol. 184, No. 12
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.12.3401-3405.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands,1 University of Freiburg, Freiburg, Germany2
Received 12 December 2001/ Accepted 15 March 2002
|
|
|---|
|
|
|---|
FBPase is an essential regulatory enzyme in the gluconeogenic pathway. It converts D-fructose-1,6-bisphosphate to D-fructose-6-phosphate, an important precursor in biosynthetic pathways. Generally, a divalent metal ion such as Mg2+, Mn2+, Co2+, or Zn2+ is required for catalytic activity. The three-dimensional structures of several FBPases have been elucidated (9, 24, 26), and all exhibit a typical sugar phosphatase fold (http://scop.mrc-lmb.cam.ac.uk/scop).
It has recently been reported that the inositol monophosphatase (I-1-Pase) (EC 3.1.3.25) from Methanococcus jannaschii (MJ0109) exhibits FBPase activity, and it has been suggested that this enzyme might be the missing FBPase in archaea (20). In addition, MJ0109 orthologs in Archaeoglobus fulgidus and Thermotoga maritima show FBPase activity (20). In an attempt to complete the set of determined glycolytic and gluconeogenic enzymes in P. furiosus, we cloned and expressed the MJ0109 ortholog from P. furiosus (48% identity on the amino acid level) in Escherichia coli and investigated its ability to function as a thermoactive FBPase.
Transcript analysis and cloning of fbpA. An ortholog (fbpA) of MJ0109 (2) was identified in the P. furiosus genome database (http://www.genome.utah.edu). This ortholog was originally designated as an extragenic suppressor, suhB. The start of the fbpA gene was predicted based on the presence and proper spacing of a potential Shine-Dalgarno sequence and on multiple alignment of the deduced amino acid sequence with those of related enzymes (Fig. 1). To test whether the fbpA gene was transcribed in P. furiosus, total RNA was isolated from a pyruvate-grown P. furiosus culture (40 mM) as described previously (25). The presence of the fbpA transcript was confirmed (data not shown) by using a reverse transcription-PCR system according to the instructions of the manufacturer (Promega) with 1 µg of P. furiosus RNA and the primers BG977 and BG978 (see below). Moreover, a recent genome-based microarray analysis of P. furiosus also revealed the expression of fbpA (designated suhB) (18).
![]() View larger version (73K): [in a new window] |
FIG. 1. Multiple sequence alignment of the deduced amino acid sequence of the P. furiosus FBPase with the sequences of its FBPase IV homologs and of I-1-Pases and FBPases from eukarya and bacteria. Abbreviations (accession numbers are given in parentheses): H.s. IMP, Homo sapiens I-1-Pase 1 (P29218); E.c. IMP, E. coli SuhB I-1-Pase (P22783); T.m. FBPIV, T. maritima TM1415 FBPase (O33832); A.f. FBPIV; A. fulgidus AF2372 FBPase (NP_071195); M.j. FBPIV, M. jannaschii MJ0109 FBPase (Q57573); P.f. FBPIV, P. furiosus FBPase (AF453319); E.c. FBP1, E. coli FBPase (P09200); S.s. FBP, Sus scrofa FBPase (P00636). Gaps introduced by the alignment are indicated by dashes. Completely conserved regions are indicated by black boxes. Highly conserved regions are shaded gray. The IMP motifs are indicated with horizontal black bars above the alignments. The FBPase motif is indicated with a horizontal gray bar under the alignment. IMP 1 motif, [FWV]-x (0, 1)-[LIVM]-D-P-[LIVM]-D-[SG]-[ST]-x (2)-[FY]-x-[HKRNSTY]; inositol monophosphatase family signature 1 (PS00629). IMP 2 motif, [WV]-D-x-[AC]-[GSA]-[GSAPV]-x-[LIVACP]-[LIV]-[LIVAC]-x (3)-[GH]-[GA]; inositol monophosphatase family signature 2 (PS00630). FBPase motif, [AG]-[RK]-[LI]-x (1, 2)-[LIV]-[FY]-E-x (2)-P-[LIVM]-[GSA] (PS00124) (http://www.expasy.ch/prosite). Asterisks denote residues involved in the Li+ binding site (24). The determined N-terminal amino acid sequence from the purified P. furiosus FBPase described in the text is underlined.
|
Overexpression and purification of FBPase. An overnight culture of E. coli BL21(DE3) harboring pLUW558 was used as a 1% inoculum in 0.5 liter of Luria-Bertani medium with 50 µg of kanamycin/ml. Gene expression was induced by adding 0.1 mM isopropyl-1-thio-ß-D-galactopyranoside (IPTG) at an optical density at 600 nm of 0.5. Growth was allowed to continue for 10 h at 37°C, and cells were harvested by centrifugation (2,200 x g for 20 min at 4°C) and resuspended in 10 ml of 50 mM Tris-HCl buffer, pH 8.0. The cells were disrupted by French press treatment (100 MPa), and cell debris was removed by centrifugation (10,000 x g for 20 min at 4°C). The resulting cell extract was heat treated for 30 min at 80°C, and the precipitated proteins were removed by centrifugation (10,000 x g for 30 min at 4°C). The heat-stable cell extract was filtered through a 0.45-µm-pore-size filter and applied to a MonoQ HR 5/5 column (1 ml; Amersham Pharmacia Biotech) equilibrated with 50 mM Tris-HCl buffer, pH 8.0. The FBPase activity eluted at 0.37 M NaCl in a linear gradient of 0.0 to 1.0 M NaCl. Active fractions were pooled and concentrated 20-fold to a final volume of 100 µl by use of a filter with a 10-kDa cutoff (Microsep; Pall Filtron). The concentrated pool was loaded on a Superdex 200 HR 10/30 gel filtration column (24 ml; Amersham Pharmacia Biotech) equilibrated with 50 mM Tris-HCl buffer, pH 7.8, containing 100 mM NaCl. The elution pattern (not shown) suggested that the active configuration was a dimer (66.8 kDa) of two identical 33-kDa subunits, which is in good agreement with the results of a sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis (data not shown). The calculated size of the subunit was slightly smaller, i.e., 27.9 kDa. The purified enzyme was desalted in 50 mM Tris-HCl buffer, pH 8.0, by use of a filter with a 10-kDa cutoff (Microsep; Pall Filtron). From 2.7 g of cell paste consisting of E. coli BL21(DE3) containing pLUW558, a total of 27.7 mg of FBPase was purified to 95% purity, as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (data not shown). To ensure that the detected activity corresponded to the P. furiosus FBPase, the N-terminal sequence of the purified enzyme was determined by the Edman degradation method to be Met-Lys-Leu-Lys-Phe-Trp-Arg-Glu-Val-Ala-Ile-Asp-Ile-Ile-Ser-Asp-Phe-Glu-Thr-Thr-Ile-Met-Pro-Phe, revealing that the obtained amino acid sequence exactly matched the N-terminal sequence of the translated fbpA from P. furiosus (Fig. 1). This indicates that the P. furiosus FBPase had been produced and purified successfully.
Temperature dependence of FBPase. For the determination of the temperature optimum, an appropriate amount of purified FBPase (6 to 30 ng) was incubated in 1-ml crimp-sealed vials containing 100 mM MOPS (morpholinepropanesulfonic acid) buffer, pH 7.4, and 10 mM MgCl2. The vials were submerged in an oil bath at temperatures varying from 20 to 120°C and preheated for 2 min, and the enzyme reaction was initiated by the injection of 15 mM fructose-1,6-bisphosphate. At different times up to 15 min, the reaction was stopped by transferring the vials to a mixture of ice and ethanol. Aliquots were taken, and the amount of fructose-6-phosphate formed was determined spectrophotometrically by measuring the reduction of NADP+ (340 nm) at room temperature in an assay with glucose-6-phosphate isomerase (EC 5.3.1.9) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49), both from Saccharomyces cerevisiae. A linear increase in fructose-6-phosphate production over time was observed, indicating that no P. furiosus FBPase was inactivated during incubation. The P. furiosus FBPase showed maximal activity at approximately 100°C (data not shown).
In accordance with first-order inactivation kinetics (data not shown), the enzyme (18 µg/ml) lost 50% of its activity after incubation for 2 h at 100°C in 50 mM Tris-HCl buffer, pH 8.0. For the determination of the melting temperature, P. furiosus FBPase was dialyzed extensively against a 100 mM sodium phosphate buffer, pH 8.0, and diluted to 0.3 mg/ml in dialysis buffer. After being degassed for 10 min, the samples were analyzed against the dialysis buffer in a differential scanning microcalorimeter (VP-DSC; MicroCal) between 50 and 125°C at 0.5°C/min. Enzyme scans were corrected with a buffer-buffer baseline, and data were analyzed with the MicroCal Origin 5.0 SR2 software package. For FBPase, an apparent melting temperature of 107.5°C was determined (data not shown), which is in good agreement with the inactivation kinetics.
Catalytic properties. The kinetic parameters of the P. furiosus FBPase were determined discontinuously at 85°C by varying the concentration of fructose-1,6-bisphosphate (between 0.005 and 5 mM) and by measuring the release of inorganic phosphate at room temperature as described previously (8). The 0.2-ml assay mixture contained 50 mM Tris-HCl buffer (pH 8.0; room temperature), 10 mM MgCl2, and 0.4 µg of purified FBPase. At this temperature, the Km and Vmax of the P. furiosus FBPase with fructose-1,6-bisphosphate were 0.32 ± 0.03 mM and 12.2 ± 0.1 U/mg, respectively, resulting in a catalytic efficiency (kcat/Km) of 17.7 s-1 mM-1. The determined affinity of the purified FBPase for fructose-1,6-bisphosphate is in good agreement with the previously determined Km of 0.5 mM (75°C) in a P. furiosus extract (16). The kinetic parameters of the purified FBPase determined at 50°C were as follows: a Km of 0.31 ± 0.06 mM, a Vmax of 0.72 ± 0.04 U/mg, and a catalytic efficiency of 1.12 s-1 mM-1. Thus, the P. furiosus FBPase clearly is a thermoactive enzyme with affinities for fructose-1,6-bisphosphate at 50 and 85°C that are similar.
The specific activities of the P. furiosus FBPase for fructose-1,6-bisphosphate and related substrates were determined at 85°C in the standard assay that measures the release of inorganic phosphate. The 1-ml assay mixture contained 50 mM Tris-HCl buffer (pH 8.0; room temperature), 2.5 mM substrate, 10 mM MgCl2, and 0.02 mg of purified FBPase. At fructose-1,6-bisphosphate concentrations above 10 mM, the enzyme was subjected to substrate inhibition (data not shown). The highest activity was obtained with fructose-1,6-bisphosphate (12.2 U/mg). In addition, myo-inositol-1-phosphate, glucose-1-phosphate, and glycerol-2-phosphate could also be dephosphorylated by the enzyme, although the activities for these substrates were relatively low (1.7 to 7.5%) (Table 1). The recently described I-1-Pase/FBPase from M. jannaschii (MJ0109) also dephosphorylates these substrates but with a higher relative activity (42 to 61%) (20) (Table 1). The P. furiosus FBPase appeared to be a rather specific phosphatase, since fructose-1-phosphate, fructose-6-phosphate, glucose-6-phosphate, phosphoenolpyruvate (PEP), 5'-AMP, 5'-ADP, and 5'-ATP could not be used as substrates under the tested conditions.
|
View this table: [in a new window] |
TABLE 1. Substrate specificity of P. furiosus FBPase compared to that of M. jannaschii MJ0109a
|
Effectors of FBPase. The effect of inhibitors on the activity of the P. furiosus FBPase was investigated by adding cations and metabolites (0 to 100 mM) to the standard enzyme assay mixture (85°C) (Table 2). The enzyme has an absolute requirement for Mg2+ (data not shown). The inhibition characteristics of the P. furiosus FBPase clearly differ from those of characterized eukaryal and bacterial FBPases as well as from those of the other presently characterized archaeal I-1-Pase/FBPase homologs. FBPase I from E. coli is very sensitive to AMP and PEP (1). FBPase II from E. coli is strongly inhibited by ATP and ADP, whereas AMP has no effect on the enzyme activity. Furthermore, FBPase II activity is enhanced in the presence of PEP (6). PEP also affects FBPase III activity, i.e., inhibition by AMP is reduced when PEP is present (7). The P. furiosus FBPase was inhibited by ADP and ATP (and to some extent by AMP), but PEP (up to 100 mM) did not influence FBPase activity at all. Therefore, PEP presumably is not an important metabolite in the regulation of FBPase in P. furiosus. In addition, glucose-6-phosphate significantly reduced P. furiosus FBPase activity in vitro (Table 2).
|
View this table: [in a new window] |
TABLE 2. Inhibitors of P. furiosus FBPase activitya
|
0.3 mM) (24). Under the test conditions we used, Li+ significantly reduced the P. furiosus FBPase activity (50% inhibitory concentration [IC50], 1 mM) (Table 2), whereas the addition of Na+ and K+ produced no effect. Previously, it was shown that I-1-Pases are also strongly inhibited by Li+ (IC50
0.3 mM) (12). These enzymes have a structural fold similar to that of FBPases (27), and both are members of the sugar phosphatase superfamily (http://scop.mrc-lmb.cam.ac.uk/scop). Inhibition of mammalian I-1-Pase by Li+ is of particular interest, since this enzyme is expressed in brain tissue and forms the main target in medical treatment of manic-depression (14). The mechanisms of the Li+ inhibition of FBPases and IMPases are believed to be essentially the same: Li+ binds at one of the metal binding sites, thereby retarding turnover or phosphate release (9, 24). The residues that constitute this metal binding site are conserved in lithium-sensitive I-1-Pase and in FBPase (Fig. 1). Remarkably, Li+ does not have such a strong effect on the T. maritima (TM1415) and M. jannaschii (MJ0109) enzymes (IC50s, 100 mM for TM1415 and >250 mM for MJ0109), although residues constituting the Li+ binding site are conserved (Fig. 1) (9). Minor variations will probably distinguish the inhibitory effect of Li+ on the I-1-Pase from that on FBPase (9). Classification of FBPases. Recently, a new classification of bacterial FBPases into three groups (FBPase I, FBPase II, and FBPase III) has been proposed (6). Eukaryal FBPases are orthologous to the bacterial FBPase I enzymes, since both contain typical FBPase domains (http://www.expasy.ch) and display no I-1-Pase activity (20). The typical FBPase domain is absent in the bacterial FBPase II and FBPase III enzymes (Table 3), suggesting that they are phylogenetically unrelated to FBPase I enzymes. Remarkably, typical I-1-Pase domains (IMP 1) are also present in the eukaryal FBPase and the bacterial FBPase I enzymes (http://www.expasy.ch). Bacterial and eukaryal I-1-Pases contain two specific domains (IMP 1 and IMP 2) and, together with the eukaryal FBPase and bacterial FBPase I enzymes, belong to the sugar phosphatase superfamily (http://scop.mrc-lmb.cam.ac.uk/scop). Comparison of the primary structure of the P. furiosus FBPase with the FBPase and IMP family signatures revealed that this enzyme contains both I-1-Pase domains (IMP 1 and IMP 2). No obvious FBPase domain could be detected in the P. furiosus sequence (Table 3) (Fig. 1). The P. furiosus FBPase is homologous to M. jannaschii MJ0109, A. fulgidus AF2372, and T. maritima TM1415, with all three enzymes having IMP 1 and IMP 2 domains present in their primary structures (Fig. 1) and possessing dual activity (i.e., FBPase and I-1-Pase activity) (20). Since these FBPases display limited sequence identity with both eukaryal and mesophilic bacterial FBPases (12 to 16% identity with FBPase I and 11 to 15% identities with FBPase II and FBPase III) but seem to be significantly related to the I-1-Pases (16 to 35% identity), we propose on the basis of sequence identity and substrate specificity that the P. furiosus FBPase and its homologs constitute a new FBPase family, type IV FBPases (FBPase IV), which is present in euryarchaeal and hyperthermophilic bacterial species and is potentially involved in gluconeogenesis. The presence of conserved domains (IMP 1) in type I and type IV FBPases and I-1-Pases, as well as the similar structural folds of these enzymes (20, 27), suggests that these enzymes share the same phylogenetic origin, as has been suggested previously (20, 27). It is tempting to speculate that the FBPase IV enzymes originally belonged to the I-1-Pase family and subsequently evolved to efficiently convert fructose-1,6-bisphosphate for function in gluconeogenesis.
|
View this table: [in a new window] |
TABLE 3. Classification of phosphatases
|
This work was supported by the Earth and Life Sciences foundation (ALW), which is subsidized by The Netherlands Organization for Scientific Research (NWO).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»